Relevant Publications June 6, 2024 Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adultsPLOS ONE August 12, 2021Enhancing influenza vaccine immunogenicity and efficacy through infection mimicry using silk microneedlesScience Direct February 11, 2020Thin silk fibroin films as a dried format for temperature stabilization of inactivated polio vaccineScience Direct August 13, 2019Enhancing humoral immunity via sustained-release implantable microneedle patch vaccinationBoopathy V.A. at al., May 9, 2019Slow delivery immunization enhances HIV neutralizing antibody and germinal center responses through modulation of immunodominanceCirelli KM et al., July 21, 2017Germinal center enhancement by extended antigen availabilityCirelli K.M. and Crotty S. October 4, 2016Sustained antigen availability during germinal center initiation enhances antibody responses to vaccinationTam HH et al., July 12, 2013Implantable silk composite microneedles for programmable vaccine release kinetics and enhanced immunogenicity in transcutaneous immunizationDeMuth PC et al.,